99 related articles for article (PubMed ID: 3540081)
1. Effect of domperidone on the release of insulin after intravenous glucose load in man.
Pezzarossa A; Vescovi PP; Cervigni C; Angelini O; Cimicchi MC; Capretti L; Campana G; Butturini U
J Endocrinol Invest; 1986 Oct; 9(5):383-8. PubMed ID: 3540081
[TBL] [Abstract][Full Text] [Related]
2. Acute elevation of endogenous prolactin does not influence glucose homeostasis in healthy men.
Vigas M; Klimes I; Jurcovicová J; Jezová D
Physiol Res; 1993; 42(5):341-5. PubMed ID: 8130181
[TBL] [Abstract][Full Text] [Related]
3. Studies on the central and peripheral dopaminergic control of PRL secretion in man: failure to demonstrate the existence of a dopamine-mediated prolactin-inhibiting factor.
Ho KY; Smythe GA; Lazarus L
Neuroendocrinology; 1985 Jun; 40(6):457-62. PubMed ID: 3925361
[TBL] [Abstract][Full Text] [Related]
4. TSH and PRL responses to domperidone and TRH in men with insulin-dependent diabetes mellitus of different duration.
Coiro V; Butturini U; Gnudi A; Volpi R; d'Amato L; Speroni G; Capretti L; Roti E; Chiodera P
Horm Res; 1987; 25(4):206-14. PubMed ID: 3108134
[TBL] [Abstract][Full Text] [Related]
5. Domperidone, an extracerebral inhibitor of dopamine receptors, stimulates thyrotropin and prolactin release in man.
Delitala G; Devilla L; Lotti G
J Clin Endocrinol Metab; 1980 Jun; 50(6):1127-30. PubMed ID: 7372791
[TBL] [Abstract][Full Text] [Related]
6. The effects of different doses of dopamine and domperidone on increases of plasma norepinephrine induced by cold pressor test in normal man.
Lieverse AG; Lefrandt JD; Girbes AR; Smit AJ; Reitsma WD
Hypertens Res; 1995 Jun; 18 Suppl 1():S221-4. PubMed ID: 8529068
[TBL] [Abstract][Full Text] [Related]
7. On the role of dopamine receptors in aldosterone secretion.
Frisina N; Buemi M; Macri' I
Ann Endocrinol (Paris); 1984; 45(6):387-91. PubMed ID: 6100228
[TBL] [Abstract][Full Text] [Related]
8. Domperidone treatment in man inhibits the fall in plasma renin activity induced by intravenous gamma-L-glutamyl-L-dopa.
Worth DP; Harvey JN; Brown J; Worral A; Lee MR
Br J Clin Pharmacol; 1986 May; 21(5):497-502. PubMed ID: 3087398
[TBL] [Abstract][Full Text] [Related]
9. Effects of dopaminergic antagonists on dopamine-induced cardiovascular and insulin secretion actions in hypertensive patients.
Forte P; Martin G; Luchsinger A; Hernandez O; Romero E; Velasco M
Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):404-6. PubMed ID: 8225687
[TBL] [Abstract][Full Text] [Related]
10. Prolactin responses to domperidone in chronic schizophrenia.
Nerozzi D; Magnani A; Dastoli C; Ferri E; Capesciotti G; Antonozzi I; Frajese G; Meltzer HY
Psychiatry Res; 1992 May; 42(2):159-69. PubMed ID: 1631251
[TBL] [Abstract][Full Text] [Related]
11. Effect of bromocriptine on insulin, growth hormone and prolactin responses to arginine in obesity.
Maccario M; Grottoli S; Procopio M; Oleandri SE; Barberis A; Ciccarelli E; Camanni F; Ghigo E
J Endocrinol Invest; 1996 Apr; 19(4):219-23. PubMed ID: 8862501
[TBL] [Abstract][Full Text] [Related]
12. Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man.
Sowers JR; Sharp B; McCallum RW
J Clin Endocrinol Metab; 1982 Apr; 54(4):869-71. PubMed ID: 7037817
[TBL] [Abstract][Full Text] [Related]
13. Interactions of dopaminergic and peptidergic factors in the control of prolactin release.
Mogg RJ; Samson WK
Endocrinology; 1990 Feb; 126(2):728-35. PubMed ID: 2298169
[TBL] [Abstract][Full Text] [Related]
14. Modulation of corticosteroid secretion by dopaminergic mechanisms in rhesus monkeys.
Sowers JR
Am J Physiol; 1982 Nov; 243(5):E375-9. PubMed ID: 7137342
[TBL] [Abstract][Full Text] [Related]
15. Dissociated response of thyrotropin and prolactin to dopamine receptor blockade with domperidone in hypothyroid subjects.
Marcondes JA; Santomauro AT; Minanni SL; Wajchenberg BL
Horm Metab Res; 1991 Dec; 23(12):605-8. PubMed ID: 1778595
[TBL] [Abstract][Full Text] [Related]
16. Small dose of domperidone potentiated the effects of TRH and serotonin on prolactin release in ovariectomized, estrogen-treated rats.
Pan JT; Teo KL
Neuroendocrinology; 1989 Oct; 50(4):387-91. PubMed ID: 2510048
[TBL] [Abstract][Full Text] [Related]
17. The extracerebral dopamine antagonist domperidone block the suppressive effect of bromocriptine on prolactin and TSH secretion in man.
Svet-Moldavsky I; Svet-Moldavsky G; Zinzar S; Holland J; Vergara C; Arlin Z; Koziner B; Clarkson B
Biomedicine; 1981 Oct; 35(5):142-4. PubMed ID: 6797487
[TBL] [Abstract][Full Text] [Related]
18. Hyperprolactinemia does not influence hypothalamic-pituitary-adrenocortical function during hypoglycemia in women.
Imrich R; Rovensky J; Cervenakova Z; Ksinantova L; Kvetnansky R; Koska J
Int J Tissue React; 2002; 24(2):73-8. PubMed ID: 12182236
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
[TBL] [Abstract][Full Text] [Related]
20. Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine- and dopaminergic stimulated GH secretion, and total plasma insulin-like growth factor-I concentrations in normal male volunteers.
Miell JP; Corder R; Pralong FP; Gaillard RC
J Clin Endocrinol Metab; 1991 Mar; 72(3):675-81. PubMed ID: 1671785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
